We are live on
!
Find out more
AVA
Atlas Venture Advisors Portfolio holdings
AUM
$122M
1-Year Est. Return
26.28%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$503M
AUM Growth
-$66.3M
(-12%)
Cap. Flow
-$27.4M
Cap. Flow
% of AUM
-5.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DraftKings
DKNG
|
+$26.9M |
| 2 |
Larimar Therapeutics
LRMR
|
+$468K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 53.26% |
| 2 | Communication Services | 46.39% |
| 3 | Healthcare | 0.35% |
Similar funds
RCWM
CCM
SO
MAM
PLC
VAM
TCM
NFGH
Atlas Venture Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Atlas Venture Advisors held 5 positions worth $503M, down 12% from $569M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Atlas Venture Advisors withdrew a net $27.4M in Q1 2024, reducing 2 holdings. Its largest reduction was DraftKings, cutting an estimated $26.9M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 53% of assets, up from 41% a quarter earlier, followed by Communication Services and Healthcare.
- Atlas Venture Advisors's biggest Q1 2024 reduction was DraftKings, cutting an estimated $26.9M.
- Atlas Venture Advisors's ten largest holdings make up 100% of its $503M portfolio in Q1 2024.
- Atlas Venture Advisors opened 0 new positions and closed 0 in Q1 2024.
- Atlas Venture Advisors's portfolio value fell 12% quarter-over-quarter to $503M.
Based on Atlas Venture Advisors's 13F filing for Q1 2024, filed 13 May 2024.